News
-
DoH Enhances Customer Experience with Comprehensive Health Insurance Services on TAMM
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, announced a set…
Read More » -
Dubai Healthcare City Authority unveils AED1.3 billion development plan
Issam Galadari: Our upcoming development plan reflects our commitment to contribute to shaping the future of healthcare infrastructure in Dubai…
Read More » -
KFSHRC Inks Agreement with Rady Institute for Genetic Screening of Newborns
King Faisal Specialist Hospital and Research Centre (KFSHRC) has signed a partnership with the Rady Children’s Institute for Genomic Medicine…
Read More » -
Revive ME to Spotlight the Future of Healthy Longevity in Abu Dhabi This November
Abu Dhabi is set to host the Middle East’s first-of-its-kind conference and exhibition dedicated to longevity science, biotechnology, regenerative medicine,…
Read More » -
ACIBADEM HEALTHCARE GROUP… Two Babies with Liver Failure from Georgia and Libya Treated in Türkiye
Two babies, a two-year-old from Libya and a four-month-old from Georgia, underwent successful liver transplants performed by Turkish doctors at…
Read More » -
Two Double Lung Transplants
For 14 years, Gabriel Gonzalez Chavez suffered from a lung condition called hypersensitivity pneumonitis which causes lung scarring, shortness of…
Read More » -
Apex Health Secures Five Prestigious Awards for Patient Experience Excellence from Arab Hospitals Federation
Apex Health, a subsidiary of Estithmar Holding Q.S.P.C. and one of the fastest-growing healthcare providers in the MENA region, has…
Read More » -
Revive ME Strengthens Industry Leadership
Revive ME, the Middle East’s pioneering conference and exhibition dedicated to longevity science, biotechnology, regenerative medicine, ultra-personalised wellness, and AI-powered…
Read More » -
KFSHRC Deputy CEO at C3 Davos of Healthcare Summit: AI Will Support, Not Replace, Healthcare Workers
Artificial intelligence is ready to play a major role in healthcare, but it must be seen as a tool to…
Read More » -
Lilly’s Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer’s disease
Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study…
Read More »